Obiekt

Ta publikacja jest chroniona prawem autorskim. Dostęp do jej cyfrowej wersji jest możliwy z określonej puli adresów ip.
Ta publikacja jest chroniona prawem autorskim. Dostęp do jej cyfrowej wersji jest możliwy z określonej puli adresów ip.

Tytuł: Feasibility of personalized adjuvant chemotherapy of gastric cancer utilizing expression of proteins associated with metabolism and pharmacodynamics of cisplatin and fluorouracyl

Abstrakt:

Gastric cancer in the western population is associated with poor prognosis. High rates of local and systemic relapse in patients undergoing potentially curative resections indicate the need of systemic therapy. The vast majority of chemotherapy regimens include fluoropirimidines or platinium based agents. These regimens are with some heterogeneity in efficacy and safety. The aim of the study is to analyse a potential relationships between expression of the aforementioned 24 proteins associated with the pharmacokinetics and pharmacodynamics and metabolism of cisplatin and 5-fluorouracil and efficacy as well as safety outcomes of adjuvant chemotherapy of gastric cancer.METHODOLOGYClinical data and specimens were taken from 119 patients with gastric cancer. The group of 24 proteins measured immunohistochemically (IHC). Protein expression were quantified by immunohistochemistry using tissue microarrays. The results were correlated with clinical parameters and efficacy and safety of chemotherapy.RESULTSAmong 119 patients after gastric surgery 50% received adjuvant chemotherapy. Lack of the expression of DPD protein significantly prolonged the median overall survival (OS) time compared to the patients with DPD expression (51 months, 95% CI 17-84 vs 11 months, 95% CI 2-21; P=0,012). Expression of MSH2 protein in tumor cells significantly prolonged the median overall survival (OS) comp ; ared to those without expression (25 months, 95% CI 9-42 vs 3 months, 95% CI 0-3; P<0,001). Multivariate analysis revealed that the Karnofsky performance status as well as tumor staging, expression of DPD, radicality of gastric resection were independent prognostic factors for gastric cancer. Cardiovascular diseases was an only statistical significant risk factor for chemotherapy-related toxicity, but not investigated proteins. CONCLUSIONSThese results indicated that among 24 analyzed proteins only the expression of MSH2 and lack of expression od DPD in tumor cells had a significant effect on median overall survival in gastric cancer patients.

Miejsce wydania:

Kraków

Stopień studiów:

2 - studia doktoranckie

Dyscyplina:

onkologia ; choroby układu trawiennego

Instytucja nadająca tytuł:

Wydział Lekarski

Promotor:

Kulig, Jan

Data wydania:

2018

Identyfikator:

oai:dl.cm-uj.krakow.pl:4407

Sygnatura:

ZB-130873

Język:

pol

Prawa dostępu:

tylko w bibliotece

Kolekcje, do których przypisany jest obiekt:

Data ostatniej modyfikacji:

13 mar 2023

Data dodania obiektu:

18 mar 2021

Liczba wyświetleń treści obiektu:

2

Liczba wyświetleń treści obiektu w formacie PDF

0

Wszystkie dostępne wersje tego obiektu:

http://dl.cm-uj.krakow.pl:8080/publication/4408

Wyświetl opis w formacie RDF:

RDF

Wyświetl opis w formacie OAI-PMH:

OAI-PMH

Nazwa wydania Data
ZB-130873 13 mar 2023
×

Cytowanie

Styl cytowania:

Ta strona wykorzystuje pliki 'cookies'. Więcej informacji